BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Bretylium Tosylate In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?
Bretylium Tosylate In Dextrose 5% In Plastic Container is a drug marketed by B Braun, Baxter Hlthcare, and Hospira Inc. and is included in three NDAs.
The generic ingredient in BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What are the global sales for BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 41 |
DailyMed Link: | BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |